Zobrazeno 1 - 10
of 625
pro vyhledávání: '"Steven E Lipshultz"'
Autor:
Marco Ricci, Yanji Xu, Harriet L Hammond, David A Willoughby, Lubov Nathanson, Maria M Rodriguez, Matteo Vatta, Steven E Lipshultz, Joy Lincoln
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e29784 (2012)
Hypoplastic Left Heart Syndrome (HLHS) is a congenital defect characterized by underdevelopment of the left ventricle and pathological compensation of the right ventricle. If untreated, HLHS is invariably lethal due to the extensive increase in right
Externí odkaz:
https://doaj.org/article/2fc4220f1b0f4b2289f0a544df2e37bc
Autor:
Paul F. Kantor, Ling Shi, Steven D. Colan, E. John Orav, James D. Wilkinson, Taye H. Hamza, Steven A. Webber, Charles E. Canter, Jeffrey A. Towbin, Melanie D. Everitt, Elfriede Pahl, Stephanie M. Ware, Paolo G. Rusconi, Jacqueline M. Lamour, John L. Jefferies, Linda J. Addonizio, Steven E. Lipshultz
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background Pediatric dilated cardiomyopathy often leads to death or cardiac transplantation. We sought to determine whether changes in left ventricular (LV) end‐diastolic dimension (LVEDD), LV end‐diastolic posterior wall thickness, and LV fracti
Externí odkaz:
https://doaj.org/article/cf15026e9b6b4c489d5bde6d3cc59281
Autor:
Lisa M. Kopp, Richard B. Womer, Cindy L. Schwartz, David H. Ebb, Vivian I. Franco, David Hall, Donald A. Barkauskas, Mark D. Krailo, Holcombe E. Grier, Paul A. Meyers, Leonard H. Wexler, Neyssa M. Marina, Katherine A. Janeway, Richard Gorlick, Mark L. Bernstein, Steven E. Lipshultz, for the Children’s Oncology Group
Publikováno v:
Cardio-Oncology, Vol 5, Iss 1, Pp 1-12 (2019)
Abstract Background Dexrazoxane protects from lower-cumulative-dose doxorubicin cardiotoxicity, but the effect of dexrazoxane in children with sarcoma treated with higher-cumulative-dose doxorubicin is unknown. Methods We evaluated children with oste
Externí odkaz:
https://doaj.org/article/c1df26e926ca40859f1f7499883d65cd
Autor:
Eric J. Chow, Sanjeev Aggarwal, David R. Doody, Richard Aplenc, Saro H. Armenian, K. Scott Baker, Smita Bhatia, Nancy Blythe, Steven D. Colan, Louis S. Constine, David R. Freyer, Lisa M. Kopp, Caroline Laverdière, Wendy M. Leisenring, Nao Sasaki, Lynda M. Vrooman, Barbara L. Asselin, Cindy L. Schwartz, Steven E. Lipshultz
Publikováno v:
Journal of Clinical Oncology. 41:2248-2257
PURPOSE For survivors of childhood cancer treated with doxorubicin, dexrazoxane is cardioprotective for at least 5 years. However, longer-term data are lacking. METHODS Within the Children's Oncology Group and the Dana Farber Cancer Institute's Child
Autor:
Nestor de la Cruz-Muñoz, Luyu Xie, Hallie J Quiroz, Onur C Kutlu, Folefac Atem, Steven E Lipshultz, M Sunil Mathew, Sarah E Messiah
Publikováno v:
Journal of the American College of Surgeons. 235(4)
Metabolic and bariatric surgery (MBS) is a safe and effective treatment option for adolescents with severe obesity, but no long-term studies are available with more than10 years of follow-up data to document sustained improved outcomes.A total of 96
Autor:
Stephanie M. Ware, James D. Wilkinson, Muhammad Tariq, Jeffrey A. Schubert, Arthi Sridhar, Steven D. Colan, Ling Shi, Charles E. Canter, Daphne T. Hsu, Steven A. Webber, Debra A. Dodd, Melanie D. Everitt, Paul F. Kantor, Linda J. Addonizio, John L. Jefferies, Joseph W. Rossano, Elfriede Pahl, Paolo Rusconi, Wendy K. Chung, Teresa Lee, Jeffrey A. Towbin, Ashwin K. Lal, Surbhi Bhatnagar, Bruce Aronow, Phillip J. Dexheimer, Lisa J. Martin, Erin M. Miller, Lynn A. Sleeper, Hiedy Razoky, Jason Czachor, Steven E. Lipshultz
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 9 (2021)
Background Pediatric cardiomyopathy is a genetically heterogeneous disease with substantial morbidity and mortality. Current guidelines recommend genetic testing in children with hypertrophic, dilated, or restrictive cardiomyopathy, but practice vari
Externí odkaz:
https://doaj.org/article/5d7842b71acd4649a3e37dd47673ab1c
Autor:
Sarju Ganatra, Anju Nohria, Sachin Shah, John D. Groarke, Ajay Sharma, David Venesy, Richard Patten, Krishna Gunturu, Corrine Zarwan, Tomas G. Neilan, Ana Barac, Salim S. Hayek, Sourbha Dani, Shantanu Solanki, Syed Saad Mahmood, Steven E. Lipshultz
Publikováno v:
Cardio-Oncology, Vol 5, Iss 1, Pp 1-12 (2019)
Abstract Background Cardiotoxicity associated with anthracycline-based chemotherapies has limited their use in patients with preexisting cardiomyopathy or heart failure. Dexrazoxane protects against the cardiotoxic effects of anthracyclines, but in t
Externí odkaz:
https://doaj.org/article/c5d38bdb4b994d0db5a10d920c6454a1
Autor:
Joseph W. Rossano, Paul F. Kantor, Robert E. Shaddy, Ling Shi, James D. Wilkinson, John L. Jefferies, Jason D. Czachor, Hiedy Razoky, Heidi S. Wirtz, Christophe Depre, Steven E. Lipshultz
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 15 (2020)
Background In adults with heart failure, elevated heart rate is associated with lower survival. We determined whether an elevated heart rate was associated with an increased risk of death or heart transplant in children with dilated cardiomyopathy. M
Externí odkaz:
https://doaj.org/article/8d374e813d844b36a913e5fe9dc6eab8
Autor:
Michael Jacob Adams, Susan G. Fisher, Steven E. Lipshultz, Roy E. Shore, Louis S. Constine, Marilyn Stovall, Ann Dozier, Kelly Thevenet-Morrison, Robert Block, Ronald G. Schwartz, Thomas A. Pearson
Publikováno v:
Cardio-Oncology, Vol 4, Iss 1, Pp 1-13 (2018)
Abstract Background Studies of cancer survivors treated with older radiotherapy (RT) techniques (pre-1990s) strongly suggest that ionizing radiation to the chest increases the risk of coronary heart disease (CHD). Our goal was to evaluate the impact
Externí odkaz:
https://doaj.org/article/8e0daf64fd4c4e2988ad68b0d4ee73f4
Autor:
Cindy L. Schwartz, Steven E. Lipshultz, Emma R. Lipshultz, Lynda M. Vrooman, Eric J. Chow, David R. Doody, Saro H. Armenian, Barbara L. Asselin, Louis S. Constine, David R. Freyer, K. Scott Baker, Lisa M. Kopp, Smita Bhatia
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:536-542
Background: Childhood cancer survivors are at risk for cardiovascular disease. We assessed the burden of potentially modifiable cardiometabolic risk factors (CRF) among survivors compared with population-matched controls. Methods: Survivors previousl